Retatrutide 10mg

Retatrutide 10 mg (Research Peptide)

Retatrutide is a synthetic, multi-receptor agonist peptide currently being investigated in preclinical and clinical research. It is designed to activate the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, making it a significant area of study in metabolic and obesity research.

Potential Research Areas

• Investigated for metabolic function
• Studied in weight management research
• Researched for glucose metabolism and insulin sensitivity
• May support appetite regulation in research models
• Investigated for energy expenditure and fat metabolism
• Studied for cardiometabolic health in clinical research

Research Applications

Retatrutide is commonly investigated in laboratory and clinical studies involving:

Obesity and weight management

Metabolic disorders

Glucose homeostasis

Energy balance

Cardiometabolic research

Endocrine physiology

Product Information

Strength: 10 mg

Lyophilised (freeze-dried) research peptide

Intended for laboratory and scientific research only

For Research Use Only.

This product is intended exclusively for laboratory and scientific research. It is not approved for human or veterinary use. The information above describes areas of ongoing scientific investigation and should not be interpreted as established therapeutic or medical benefits.